A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)
Condition(s):Healthy VolunteersLast Updated:June 4, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Healthy VolunteersLast Updated:June 4, 2012Completed
Condition(s):Chronic Kidney Disease; Chronic Kidney Disease on HemodialysisLast Updated:March 23, 2015Completed
Condition(s):Chronic Kidney Disease; HyperphosphatemiaLast Updated:March 20, 2015Completed
Condition(s):Chronic Kidney Disease Requiring Chronic Dialysis; HyperphosphatemiaLast Updated:June 2, 2021Completed
Condition(s):Hyperparathyroidism; Chronic Kidney DiseaseLast Updated:November 1, 2016Completed
Condition(s):HealthyLast Updated:June 15, 2021Completed
Condition(s):Hemodialysis; Hyperphosphatemia; Cardiovascular EventsLast Updated:August 5, 2014Completed
Condition(s):Kidney Failure, ChronicLast Updated:May 1, 2015Completed
Condition(s):Diabetic NephropathyLast Updated:April 9, 2014Completed
Condition(s):Hyperphosphataemia; Chronic Kidney DiseaseLast Updated:March 23, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.